# Zinc Supplementation With Botulinum Toxin for Overactive Bladder

> **NCT07405554** · PHASE2 · RECRUITING · sponsor: **Endeavor Health** · enrollment: 72 (estimated)

## Conditions studied

- Overactive Bladder (OAB)

## Interventions

- **DRUG:** Zinc Citrate Oral Capsule
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07405554
- **Lead sponsor:** Endeavor Health
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-26
- **Primary completion:** 2026-05
- **Final completion:** 2026-12
- **Target enrollment:** 72 (ESTIMATED)
- **Last updated:** 2026-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07405554

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07405554, "Zinc Supplementation With Botulinum Toxin for Overactive Bladder". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT07405554. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*